Rhythm360

by RhythmScience  · Based in United States → — Revolutionizing cardiac care with RhythmScience: The most comprehensive platform for cardiology.
Cardiology

Flexible pricing model that scales with clinic size and platform usage.

Overview

Rhythm360 is an AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and significantly reducing alert fatigue. It operates as a vendor-neutral, HIPAA-compliant cloud infrastructure, designed to integrate data from all major OEM manufacturers (including Medtronic, Abbott, Boston Scientific, and Biotronik) through advanced APIs, HL7, XML, and computer vision for PDF parsing. The platform offers AI-driven alert triage, bi-directional EHR integration, automated CPT code documentation, and secure mobile access for clinicians. Rhythm360 aims to simplify complex healthcare data to nurture patient health and empower care teams by transforming disparate device data into unified, actionable intelligence.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik)
  • AI-driven alert triage (80% faster response times, reduces alert fatigue)
  • Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity)
  • Automated CPT code documentation and billing (e.g., 93298, 93299, 99454, 99453, 99457)
  • HIPAA-compliant mobile application for clinicians
  • AI Data Normalization (API, HL7, XML, PDF parsing via computer vision)
  • Optional 24/7/365 oversight by certified cardiac technicians (CCTs)
  • Heart Failure Management (predictive algorithms, GDMT optimization)
  • Hypertension Management (blood pressure trending, medication adherence)
  • Superior Data Reliability (>99.9% transmissibility via redundant feeds, AI gap-filling)

Use Cases

  • Unified Cardiac Implantable Electronic Device (CIED) monitoring
  • Remote Patient Monitoring (RPM) for chronic cardiac conditions (Heart Failure, Hypertension)
  • Reducing alert fatigue and prioritizing critical events for clinicians
  • Automating billing and revenue cycle management for RPM services
  • Improving clinical decision support and patient outcomes
  • Streamlining cardiology practice workflows and reducing administrative overhead

What Physicians Need to Know

ECG/EKG Analysis Capability
Rhythm360 offers direct electrocardiogram integration, utilizing hospital-grade, 12-lead EKGs from QT Medical for home-based monitoring. AI systems analyzing ECG data can rule out heart attacks with 99.6% accuracy and achieve over 95% accuracy for detecting arrhythmias like atrial fibrillation and ventricular tachycardia by filtering noise and motion artifacts in real-time ECG streams.
Arrhythmia Detection Accuracy
Rhythm360's AI detects critical arrhythmias such as ventricular tachycardia, atrial fibrillation, and device malfunctions across all CIED types. Its advanced alert triage maintains clinical accuracy above 95% for arrhythmia detection. The AI engine uses computer vision and pattern recognition to surface clinically significant alerts.
Heart Failure Risk Prediction
Rhythm360 supports comprehensive heart failure management. RhythmScience has licensed an innovative Heart Failure-AI (HF-AI) algorithm from Cedars-Sinai, which provides personalized recommendations for Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction. This algorithm has shown cardiologists agreeing with AI recommendations 90.8% of the time, doubling the use of lifesaving medications and leading to a 74% reduction in hospitalizations. The platform also offers modules for remote monitoring of heart failure, including automated tracking of weight, blood pressure, and symptoms for early intervention.
Cardiac Monitoring Integration
Rhythm360 is a vendor-neutral platform that unifies data from all major CIED manufacturers (Medtronic, Boston Scientific, Abbott, Biotronik) and various cardiac devices like pacemakers, ICDs, loop recorders, MCOTs, ECG patches, and specialized sensors (e.g., CardioMEMS) into a single view. It achieves over 99.9% data transmissibility through redundant data feeds, AI-based gap filling, and computer vision technology.
AHA/ACC Guideline Alignment
The integrated HF-AI algorithm provides personalized recommendations for Guideline-Directed Medical Therapy (GDMT), a cornerstone of heart failure treatment, indicating alignment with established guidelines.
Real-Time Alert Capability
Rhythm360 features AI-driven alert triage that filters non-actionable alerts and prioritizes critical arrhythmias like VT and AFib, reducing alert fatigue by approximately 80% and speeding interventions. This system cuts response times for critical events by 80%. Critical events remain visible even during technical issues, and clinicians have mobile access to view and respond to alerts. Optional 24/7/365 oversight by certified cardiac technicians is also available.
Physician Tip

Leverage Rhythm360's vendor-neutral platform to consolidate all cardiac device data, eliminating the need for multiple OEM portal logins and streamlining workflows. Utilize the AI-driven alert triage to significantly reduce alert fatigue and focus on clinically critical events, enabling faster interventions for arrhythmias and device malfunctions. Maximize the bi-directional EHR integration for seamless data flow, reduced manual entry, and accurate documentation for automated billing of remote monitoring CPT codes. For heart failure patients, the integrated HF-AI algorithm can provide personalized Guideline-Directed Medical Therapy (GDMT) recommendations, potentially improving outcomes and reducing hospitalizations. Take advantage of mobile access to stay connected to patient monitoring and respond to critical alerts on-call, enhancing patient safety and clinician flexibility. Consider implementing the platform for comprehensive management of chronic conditions like heart failure and hypertension to expand care options and support value-based care models.

Rhythm360 offers comprehensive bi-directional EHR integration with all major EHR vendors, including Epic, Cerner, Athenahealth, eClinicalWorks, and Greenway Health, through HL7 and advanced API integrations (Smart on FHIR). It is a vendor-neutral platform that aggregates data from all major CIED manufacturers (Medtronic, Boston Scientific, Abbott, Biotronik). The platform also integrates with external remote patient monitoring devices and sensors, such as PA Pressure Sensors, blood pressure cuffs, weight scales, and remote 12-lead ECGs (e.g., via QT Medical). Data ingestion supports various formats including APIs, HL7 feeds, XML files, and unstructured PDFs through computer vision technology.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Flexible pricing model that scales with clinic size and platform usage.
  • SaaS-based solution; scales with clinic size and platform usage
  • Described as having 'premium pricing' as a potential con
DeploymentCloud-based SaaS platform
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

Rhythm360 integrates data from various FDA-defined and FDA-cleared remote patient monitoring devices. It also utilizes AI-powered analysis capabilities similar to FDA-cleared software for ECG interpretation. The platform itself is not explicitly stated as FDA-cleared in the same manner as a medical device.

Integrations
EHR Not specified
Specialties Cardiology

What the Web Says

Rhythm360 by RhythmScience is a cloud-based, vendor-neutral platform designed to unify cardiac monitoring data from various devices, including implanted cardiac devices (CIEDs), wearables, and at-home connected devices. It aims to streamline workflows for healthcare providers, reduce alert fatigue through AI-powered triage, and improve revenue capture through automated billing and documentation. Physicians and healthcare IT professionals highlight its ability to consolidate data from multiple manufacturers into a single dashboard, addressing a common pain point in cardiac remote monitoring.

Overall: Positive

Strengths

  • Vendor-neutral platform consolidates data from all major cardiac device manufacturers (Medtronic, Boston Scientific, Abbott, Biotronik) into a single dashboard, eliminating the need for multiple OEM portals.
  • AI-powered alert triage reduces alert fatigue by up to 80% and prioritizes critical events, leading to faster response times (e.g., from 4 hours to 45 minutes).
  • Automated billing and CPT code capture can increase remote monitoring revenue by up to 300% by reducing documentation gaps and improving compliance.
  • Bi-directional EHR integration with major systems like Epic and Cerner streamlines data flow, automates documentation, and improves team efficiency.
  • High data transmissibility (greater than 99.9%) ensures critical information is not lost, even during OEM downtime, through redundant feeds and AI.
  • Secure, HIPAA-compliant mobile app allows clinicians to review transmissions, sign reports, and coordinate care remotely, improving continuity of care.

Limitations

  • Limited independent reviews from G2, Capterra, or general tech reviewers were found in the search results.
  • Reddit discussions, as cited by RhythmScience itself, highlight common pain points in remote monitoring systems generally, such as missed critical alerts, heavy administrative work from multiple OEM portals, and unreliable data transmission, which Rhythm360 aims to solve.
  • The Apple App Store shows only one rating for both the provider and patient apps, limiting insights into user experience from those platforms.
  • While RhythmScience highlights its advantages over competitors, detailed third-party comparative analyses were not extensively found.
  • The information primarily comes from RhythmScience's own website and promotional materials, which may present a biased view.
  • No specific cons were identified from independent physician or healthcare IT reviews outside of RhythmScience's own comparative content.

Based on reviews from: RhythmScience.com, Apple App Store, HMP Global Learning Network, Epic Showroom

Last updated: 2026-07-24

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rhythm360

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

RhythmScience
Cardiac Remote Monitoring: Devices, Costs & Medicare 2026
Rhythm360 addresses alert fatigue with AI-powered triage, reducing critical-alert response times by up to 80% and ensuring high data transmissibility. It supports both CIED monitoring and chronic-condition RPM for heart failure and hypertension, with automated billing for 2026 CPT codes.
2026-07
RhythmScience
Heart Failure Remote Monitoring: 10-Step Implementation
Rhythm360 is a vendor-neutral, HIPAA-compliant platform designed to streamline heart failure remote monitoring programs. It features AI-powered alert triage, automated CPT documentation, and bi-directional EHR integration, which helps eliminate fragmentation and manual overhead.
2026-07
RhythmScience
Real-Time Arrhythmia Monitoring Platforms for Cardiology
Rhythm360 reduces alert fatigue through AI-powered triage, filtering non-actionable noise and surfacing clinically significant events. The platform also offers optional 24/7/365 oversight by certified cardiac technicians and supports bi-directional EHR integration with major systems like Epic and Cerner.
2026-06
RhythmScience
Healthcare Data Analytics Guide for Cardiology Clinics 2026
Rhythm360 offers vendor-neutral data integration, AI alert triage, and automated billing in one cardiac-focused platform, unifying CIED and RPM data from all major manufacturers. It helps cardiology practices with remote patient monitoring for heart failure and hypertension, and intelligent alert prioritization.
2026-02
RhythmScience
RhythmScience Licenses Groundbreaking AI Algorithm from Cedars-Sinai to Optimize Heart Failure Treatment
RhythmScience licensed the exclusive rights to Cedars-Sinai's innovative heart failure u2013 artificial intelligence (HF-AI) algorithm, integrating it into the Rhythm360 platform to optimize therapeutic treatments for heart failure patients. The HF-AI algorithm analyzes patient data to provide personalized recommendations for Guideline-Directed Medical Therapy (GDMT).
2025-09
RhythmScience
RhythmScience Secures $6M Series A Investment Led by Cedars-Sinai Health Ventures
RhythmScience closed a $6M Series A funding round led by Cedars-Sinai Health Ventures, with participation from OCA Ventures and TenOneTenVentures. This investment will accelerate the development of the Rhythm360 cardiology data platform, which provides a complete data system across hypertension, heart failure, and rhythm disorders.
2023-03
StartUs Insights
10 New Cardiac Solutions Supporting Heart Health - StartUs Insights
RhythmScience's Rhythm360 platform offers remote cardiac device monitoring, enabling bidirectional EHR integration and automated billing. It detects arrhythmias and cardiac device faults, alerting doctors in real-time, and includes compliance tools and comprehensive cardiology reports.
2024-09
EP Lab Digest
News | EP Lab Digest
EP Lab Digest mentioned Rhythm360 (RhythmScience) as a CIED and HF Patient Management solution in their July 2025 news.
2025-07

Videos

Product demos, reviews, and walkthroughs for Rhythm360.

View all on YouTube

Frequently Asked Questions

Rhythm360 is designed for seamless, bi-directional integration with major EHR platforms like Epic and Cerner, utilizing advanced API integration and HL7 messaging. This allows it to unify cardiac implantable electronic device (CIED) and chronic disease data, providing insights and alerts directly within the physician's existing workflow and reducing administrative burden.
Rhythm360 is built on a HIPAA-compliant cloud infrastructure, employing robust encryption (e.g., end-to-end AES-256), access controls, and de-identification protocols to safeguard patient data. It adheres strictly to HIPAA regulations, which govern how Protected Health Information (PHI) may be used or disclosed to AI tools, requiring measures like Business Associate Agreements (BAAs) with vendors.
While Rhythm360's AI is highly effective in prioritizing critical cardiac events and reducing alert fatigue, like all AI, it has limitations. AI systems are trained for specific tasks and may struggle with rare conditions or data not well-represented in their training sets, requiring continuous monitoring for algorithmic bias and the need for diverse datasets. Physicians must understand that AI provides support, not a replacement for clinical judgment.
While specific pricing details for Rhythm360 are not explicitly stated, healthcare AI pricing models often include subscription-based, usage-based, or hybrid models, sometimes tiered by user count or features. These models aim to align with clinical value and budget constraints, with enterprise-level AI implementations potentially costing over $300,000, plus ongoing retraining costs.
Rhythm360 distinguishes itself as a vendor-neutral platform that unifies CIED and chronic disease data from all major manufacturers, unlike systems tied to specific device makers. Its AI-driven alert triage system cuts response times for critical cardiac events by up to 80% and includes automated CPT billing, aiming to improve both patient outcomes and practice revenue.
Rhythm360 functions as a clinical decision support tool, augmenting human intelligence rather than replacing it. Physicians must critically evaluate and validate AI-generated recommendations within the full clinical context, as human expertise remains essential for minimizing risks and ensuring ethical considerations are met.
Rhythm360 is designed to adhere to relevant regulatory frameworks for medical device software. While specific FDA clearance for Rhythm360 itself is not detailed, AI/ML software as a medical device (SaMD) generally falls under FDA regulation, with many devices cleared via the 510(k) pathway. The FDA encourages the development of innovative, safe, and effective AI-enabled medical devices.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-22 | First Added: 2026-04-22
AI Tool Finder
AI-powered search. Results may not be comprehensive.